These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7615052)

  • 1. Hypoplastic acute myeloid leukaemia with 7 years of complete remission by low-dose cytosine arabinoside therapy alone.
    Mori H; Fuchigami K; Nagai K; Kohno T; Maeda T; Nakamura H; Kuriyama K; Izumikawa K; Tomonaga M
    Eur J Haematol; 1995 Jul; 55(1):59-60. PubMed ID: 7615052
    [No Abstract]   [Full Text] [Related]  

  • 2. Concomitant chronic lymphocytic leukemia (CLL) and acute myeloid leukemia. Complete remission of CLL achieved with high-dose cytosine arabinoside.
    Caballero MD; González M; Cañizo MC; Orfao A; Nieto MJ; San Miguel JF
    Leukemia; 1992 Aug; 6(8):856-8. PubMed ID: 1640739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose cytosine arabinoside in acute myeloid leukemia: remission is not due to differentiation induction.
    Pinkerton PH; London B; Cowan DH
    Am J Hematol; 1985 Aug; 19(4):415-7. PubMed ID: 3861090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fludarabine and cytosine-arabinoside for poor-risk acute myeloid leukemia.
    Russo D; Candoni A; Grattoni R; Bertone A; Zaja F
    Haematologica; 1998 Mar; 83(3):281-2. PubMed ID: 9573683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of refractory leukemia with high-dose cytosine arabinoside.
    Klener P; Háber J
    Neoplasma; 1985; 32(1):113-7. PubMed ID: 3856754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral neuropathy caused by high-dose cytosine arabinoside treatment in a patient with acute myeloid leukemia.
    Saito T; Asai O; Dobashi N; Yano S; Osawa H; Takei Y; Takahara S; Ogasawara Y; Yamaguchi Y; Minami J; Usui N
    J Infect Chemother; 2006 Jun; 12(3):148-51. PubMed ID: 16826348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complete remission achieved by high dose cytosine arabinoside therapy in the 4th relapse of AML].
    Sai M; Naganuma Y; Aoki I; Toyama K
    Rinsho Ketsueki; 1986 Jun; 27(6):952-5. PubMed ID: 3463813
    [No Abstract]   [Full Text] [Related]  

  • 8. Adriamycin-cytosine arabinoside therapy for adult acute myelocytic leukemia.
    Preisler HD; Bjornsson S; Henderson ES
    Cancer Treat Rep; 1977; 61(1):89-92. PubMed ID: 324625
    [No Abstract]   [Full Text] [Related]  

  • 9. Sucessful treatment of severe bone pain and acute arthritis in chronic myelomonocytic leukaemia by cytosine arabinoside.
    Douer D; Weinberger A; Djaldetti M; Pinkhas J; De Vries
    Ann Rheum Dis; 1977 Apr; 36(2):192-3. PubMed ID: 266396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-remission therapy of adult acute myeloid leukemia: high dose cytosine-arabinoside versus other consolidation regimens.
    Zeremski V; Savić A
    Med Pregl; 2014; 67(3-4):83-90. PubMed ID: 24961049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensified therapy for acute myeloid leukemia.
    Bishop JF
    N Engl J Med; 1994 Oct; 331(14):941-2. PubMed ID: 8078557
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of acute myeloid leukaemia according to the Hammersmith protocol: preliminary report.
    Paolino W; Resegotti L; Rossi M; Infelise V
    Br Med J; 1973 Sep; 3(5880):567-8. PubMed ID: 4516626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytosine arabinoside in the treatment of acute myeloblastic leukaemia.
    Bailey CC; Geary CG; Israëls MC; Whittaker JA; Brown MJ; Weatherall DJ
    Lancet; 1971 Jun; 1(7712):1268-71. PubMed ID: 4104719
    [No Abstract]   [Full Text] [Related]  

  • 14. Disappearance of AML1-MTG8 transcript by reverse transcriptase polymerase chain reaction in a patient in remission of acute myeloid leukemia (M2) after low-dose cytosine arabinoside.
    Sawada H; Serino Y; Wake A; Yamasaki Y; Izumi Y
    Leuk Res; 1998 Sep; 22(9):853-7. PubMed ID: 9716019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission.
    Cassileth PA; Harrington DP; Appelbaum FR; Lazarus HM; Rowe JM; Paietta E; Willman C; Hurd DD; Bennett JM; Blume KG; Head DR; Wiernik PH
    N Engl J Med; 1998 Dec; 339(23):1649-56. PubMed ID: 9834301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage chemotherapy containing moderate-dose cytosine arabinoside and mitoxantrone for relapsed and resistant acute myeloid leukaemia.
    Liang R; Chiu E; Chan TK; Todd D
    Cancer Chemother Pharmacol; 1991; 28(1):74-6. PubMed ID: 2040037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated hyperbilirubinemia following standard dose cytosine arabinoside in a patient with relapsed acute myeloid leukemia.
    Altundag O; Altundag K; Celik I; Turker A; Kars A
    Am J Hematol; 2004 Apr; 75(4):263-4. PubMed ID: 15054828
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of acute myeliod leukaemia.
    Friend JH; Giles C; Richardson SG
    J Clin Pathol; 1974 Jan; 27(1):53-4. PubMed ID: 4522738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B.
    Mayer RJ; Davis RB; Schiffer CA; Berg DT; Powell BL; Schulman P; Omura GA; Moore JO; McIntyre OR; Frei E
    N Engl J Med; 1994 Oct; 331(14):896-903. PubMed ID: 8078551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selective use of AMSA following high-dose cytarabine in patients with acute myeloid leukaemia in relapse: a Leukemia Intergroup study.
    Larson RA; Day RS; Azarnia N; Bennett JM; Browman G; Goldberg J; Gottlieb A; Grunwald H; Miller K; Raza A
    Br J Haematol; 1992 Oct; 82(2):337-46. PubMed ID: 1419816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.